NeuroPace
Stock Forecast, Prediction & Price Target
NeuroPace Financial Estimates
NeuroPace Revenue Estimates
NeuroPace EBITDA Estimates
NeuroPace Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $45.18M N/A | $45.52M 0.74% | $65.42M 43.71% | Avg: $89.20M Low: $86.45M High: $91.80M avg. 36.35% | Avg: $108.95M Low: $105.76M High: $111.48M avg. 22.14% | Avg: $152.21M Low: $147.74M High: $155.74M avg. 39.69% | Avg: $195.48M Low: $189.74M High: $200.01M avg. 28.42% |
Net Income
% change YoY
| $-38.10M N/A | $-53.37M -40.04% | $-32.95M 38.24% | Avg: $-29.40M Low: $-32.31M High: $-12.40M avg. 10.76% | Avg: $-17.82M Low: $-23.64M High: $4.65M avg. 39.37% | Avg: $-7.23M Low: $-7.45M High: $-6.96M avg. 59.39% | Avg: $6.97M Low: $6.71M High: $7.19M avg. 196.42% |
EBITDA
% change YoY
| $-28.37M N/A | $-39.55M -39.39% | $-22.83M 42.26% | Avg: $-48.77M Low: $-50.19M High: $-47.26M avg. -113.60% | Avg: $-59.57M Low: $-60.95M High: $-57.82M avg. -22.14% | Avg: $-83.22M Low: $-85.15M High: $-80.78M avg. -39.69% | Avg: $-106.88M Low: $-109.36M High: $-103.74M avg. -28.42% |
EPS
% change YoY
| -$1.56 N/A | -$2.17 -39.10% | -$1.27 41.47% | Avg: -$1 Low: -$1.25 High: -$0.48 avg. 21.16% | Avg: -$0.58 Low: -$0.91 High: $0.18 avg. 41.98% | Avg: -$0.28 Low: -$0.29 High: -$0.27 avg. 51.80% | Avg: $0.27 Low: $0.26 High: $0.28 avg. 196.42% |
Operating Expenses
% change YoY
| $57.17M N/A | $73.28M 28.18% | $75.29M 2.74% | Avg: $76.92M Low: $74.55M High: $79.17M avg. 2.16% | Avg: $93.96M Low: $91.20M High: $96.14M avg. 22.14% | Avg: $131.26M Low: $127.41M High: $134.30M avg. 39.69% | Avg: $168.58M Low: $163.63M High: $172.49M avg. 28.42% |
FAQ
What is NeuroPace stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 76.49% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -32.31M, average is -29.40M and high is -12.40M.
What is NeuroPace stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 31.65% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $86.45M, average is $89.20M and high is $91.80M.
What is NeuroPace stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 77.84% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$1.25, average is -$1 and high is $-0.48.
What is the best performing analyst?
In the last twelve months analysts have been covering NeuroPace stock. The most successful analyst is Frank Takkinen.